Silverarc Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Silverarc Capital Management, LLC
- $416 Million
- Q4 2024
A detailed history of Silverarc Capital Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 65,955 shares of TARS stock, worth $3.21 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
65,955
Previous 40,000
64.89%
Holding current value
$3.21 Million
Previous $1.32 Million
177.64%
% of portfolio
0.88%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$159 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$158 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$123 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$122 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$110 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.3B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...